Home / Expertise / Life Sciences & Healthcare
side view of scientist looking into microscope in bright research lab

Life Sciences & Healthcare

Austria

With over 150 international specialist lawyers across CMS and the support of the Life Sciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations we help shape the legal frameworks impacting the life sciences & healthcare sector.

We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice and compliance. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Read more Read less

Choose area

    Medical Law

    Legal questions are becoming increasingly relevant in the medical field, driven in part by the intended austerity and restructuring mandates of recent years. How do health care institutions comply with the multitude of legal requirements and yet still remain commercially viable? This is just one of the many challenges that we can help you meet.

    Read more

    Feed

    Show only
    01/03/2019
    BREXIT: What do phar­ma­ceut­ic­al and med­ic­al device com­pan­ies...
    17 Jan 20
    New guid­ance on cy­ber­se­cur­ity for med­ic­al devices pub­lished
    In Decem­ber 2019, the Med­ic­al Device Co­ordin­a­tion Group (“MD­CG”) is­sued a new guid­ance to help med­ic­al device man­u­fac­tur­ers meet the cy­ber­se­cur­ity re­quire­ments in the Med­ic­al Devices Reg­u­la­tion (“MDR”)...
    17/05/2018
    Dis­tri­bu­tion and mar­ket­ing of drugs in Aus­tria: over­view
    A Q&A guide to dis­tri­bu­tion and mar­ket­ing of drugs...
    15 Jan 20
    Can newly dis­covered can­nabis com­pounds be pro­tec­ted by pat­ents?
    A break­through dis­cov­ery has re­cently hit the news: tet­rahy­drocan­nabi­phorol (THCP) and can­na­bid­i­phorol (CB­DP), two new can­nabin­oid com­pounds, have been dis­covered in Can­nabis sativa and char­ac­ter­ised...
    15/01/2018
    Lifes­ci­ences Ex­pert Gab­ri­ela Staber Ap­poin­ted Part­ner...
    23 Dec 19
    So­cial Me­dia and mHealth Data EMA / HMA Re­port
    New and in­nov­at­ive tech­no­lo­gies have led to a huge in­crease in data com­ing from sources that haven’t pre­vi­ously been used with­in the reg­u­lated medi­cines in­dustry. In re­cog­ni­tion of this ex­plo­sion of...
    01/01/2018
    Good medi­cine in­stead of bit­ter pills
    Bro­chure Med­ic­al Law
    20 Dec 19
    ‘Dar­unavir’ CJEU re­fer­ral with­drawn - Art­icle 3(a) of the SPC Reg­u­la­tion
    At the end of Septem­ber, we re­por­ted here on the pub­lic­a­tion of AG Hogan’s Opin­ion on the joint re­fer­rals from the Ger­man Bundes­pat­ent­gericht (case C-650/17) for Mer­ck’s sitaglipt­in product and from...
    01/01/2018
    For a healthy pro­spect
    Bro­chure Lifes­ci­ences
    17 Dec 19
    The rise of pat­ent wars in Europe’s gene ther­apy space
    The gene ther­apy in­dustry is in an ex­cit­ing phase of growth, un­der­go­ing sig­ni­fic­ant M&A activ­ity, product sales and new mar­ket­ing au­thor­isa­tions that are be­ing is­sued with in­creas­ing reg­u­lar­ity glob­ally....
    10/08/2016
    Passing on pa­tient in­form­a­tion to law en­force­ment au­thor­it­ies
    Ärzte Krone
    15 Nov 19
    Brexit and data pro­tec­tion: what to do next (when you don’t know what’s...
    Whilst the threat of a no-deal Brexit has been aver­ted for now, the fu­ture is by no means cer­tain. We have high­lighted some of the key is­sues for UK-based or­gan­isa­tions, and the EEA or­gan­isa­tions that...